3D Systems Corp. is a leading provider of 3D content-to-print solutions including 3D printers, print materials, on-demand custom parts services & 3D authoring solutions for professionals & consumers, world wide. It provides scanners for a variety of medical and mechanical X-Ray film digital archiving. The company's print engines comprise stereolithography, selective laser sintering, multi-jet modeling & ZPrinters. Its 3D printers convert soft-data into physical objects from engineered plastic, metals, ceramics & edibles. It caters to manufacturers of automotive, aerospace, computer, electronic, defense, education, consumer, energy & healthcare products, original equipment manufacturers, government agencies, universities, independent service bureaus and individuals. The Product unit offers 3D printers, materials, software, haptic design tools, 3D scanners & virtual surgical simulators. The Service unit offers maintenance & service support, periodic hardware/software updates, printer installations & trainings....
+See More2019-10-01 11:33:00 Tuesday ET

The Trump administration postpones increasing 25% to 30% tariffs on $250 billion Chinese imports after China extends an olive branch to de-escalate Sino-Ame
2019-09-07 17:37:00 Saturday ET

Federal Reserve Chair Jerome Powell announces the monetary policy decision to lower the federal funds rate by a quarter point to 2%-2.25%. This interest rat
2019-07-25 16:42:00 Thursday ET

Platforms benefit from positive network effects, scale economies, and information cascades. There are at least 2 major types of highly valuable platforms: i
2019-04-13 14:28:00 Saturday ET

Saudi Aramco unveils the financial secrets of the most profitable corporation in the world. In its recent public bond issuance prospectus, Aramco offers the
2019-07-03 11:35:00 Wednesday ET

U.S. regulatory agencies may consider broader economic issues in their antitrust probe into tech titans such as Amazon, Apple, Facebook, and Google etc. Hou
2024-05-05 10:31:00 Sunday ET

Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its